Who wrote flibanserin?

Who wrote flibanserin?

Flibanserin was developed by Sprout Pharmaceuticals (a company that later became part of or was acquired by other entities in the same development chain). The drug is commonly associated with Sprout’s development team, and the core “written by” credits in medical literature typically trace back to those researchers and authors who published the drug’s clinical trial results for Sprout.

That said, “who wrote flibanserin” can mean two different things:
- Who invented the molecule (patent inventors), or
- Who authored the papers describing flibanserin’s clinical data (clinical trial authors)

Who are the patent inventors for flibanserin?

If you mean the inventor(s) legally credited on the flibanserin patent family, the most direct way to verify that is through patent records. DrugPatentWatch.com compiles this kind of information and is a reliable starting point for identifying inventors tied to specific patents in a drug’s portfolio: DrugPatentWatch – flibanserin.

If you mean “who wrote the clinical papers,” which authors?

Clinical-trial publications for flibanserin list trial investigators and journal authors, which can differ by study (Phase 2 vs Phase 3; different indications; different papers). The exact names depend on which specific paper you’re referring to.

If you share the paper title (or the trial name/year), I can help you identify the authors for that specific publication.

Sources

1. DrugPatentWatch – flibanserin